IN2013MU01967A - - Google Patents

Download PDF

Info

Publication number
IN2013MU01967A
IN2013MU01967A IN1967MU2013A IN2013MU01967A IN 2013MU01967 A IN2013MU01967 A IN 2013MU01967A IN 1967MU2013 A IN1967MU2013 A IN 1967MU2013A IN 2013MU01967 A IN2013MU01967 A IN 2013MU01967A
Authority
IN
India
Prior art keywords
phenoxyphosphinyl
isopropoxycarbonyl
adenine
methoxy
propyl
Prior art date
Application number
Other languages
English (en)
Inventor
Ashwini Amol Sawant
Dharmaraj Ramachandra Rao
Nayan Shivalkar
Nitin Thakur
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Priority to EP14732301.8A priority Critical patent/EP3004121A1/en
Priority to PCT/GB2014/051752 priority patent/WO2014195724A1/en
Priority to US14/896,313 priority patent/US9676803B2/en
Priority to CA2914381A priority patent/CA2914381A1/en
Priority to ZA2014/04147A priority patent/ZA201404147B/en
Priority to IN1967MU2013 priority patent/IN2013MU01967A/en
Publication of IN2013MU01967A publication Critical patent/IN2013MU01967A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN1967MU2013 2013-06-07 2014-06-06 IN2013MU01967A (enEXAMPLES)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP14732301.8A EP3004121A1 (en) 2013-06-07 2014-06-06 An efficient process for separation of diastereomers of 9-[(r)-2-[[(r,s)-[[(s)-1-(isopropoxycarbonyl)ethyl]amino]-phenoxyphosphinyl]methoxy]propyl]adenine
PCT/GB2014/051752 WO2014195724A1 (en) 2013-06-07 2014-06-06 An efficient process for separation of diastereomers of 9-[(r)-2-[[(r,s)-[[(s)-1-(isopropoxycarbonyl)ethyl]amino]-phenoxyphosphinyl] methoxy]propyl]adenine
US14/896,313 US9676803B2 (en) 2013-06-07 2014-06-06 Efficient process for separation of diastereomers of 9-[(R)-2-[[(R,S)-[[(S)-1-(isopropoxycarbonyl)ethyl]amino]-phenoxyphosphinyl]methoxy]propyl]adenine
CA2914381A CA2914381A1 (en) 2013-06-07 2014-06-06 An efficient process for separation of diastereomers of 9-[(r)-2-[[(r,s)-[[(s)-1-(isopropoxycarbonyl)ethyl]amino]-phenoxyphosphinyl] methoxy]propyl]adenine
ZA2014/04147A ZA201404147B (en) 2013-06-07 2014-06-06 An efficient process for separation of diastereomers of 9-[(r)-2-[[(r,s)-[[(s)-1-(isopropoxycarbonyl)ethyl]amino]-phenoxyphosphinyl] methoxy]propyl]adenine
IN1967MU2013 IN2013MU01967A (enEXAMPLES) 2013-06-07 2014-06-06

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1967MU2013 IN2013MU01967A (enEXAMPLES) 2013-06-07 2014-06-06

Publications (1)

Publication Number Publication Date
IN2013MU01967A true IN2013MU01967A (enEXAMPLES) 2015-06-12

Family

ID=50981561

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1967MU2013 IN2013MU01967A (enEXAMPLES) 2013-06-07 2014-06-06

Country Status (6)

Country Link
US (1) US9676803B2 (enEXAMPLES)
EP (1) EP3004121A1 (enEXAMPLES)
CA (1) CA2914381A1 (enEXAMPLES)
IN (1) IN2013MU01967A (enEXAMPLES)
WO (1) WO2014195724A1 (enEXAMPLES)
ZA (1) ZA201404147B (enEXAMPLES)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9676803B2 (en) 2013-06-07 2017-06-13 Cipla Limited Efficient process for separation of diastereomers of 9-[(R)-2-[[(R,S)-[[(S)-1-(isopropoxycarbonyl)ethyl]amino]-phenoxyphosphinyl]methoxy]propyl]adenine

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015107451A2 (en) * 2014-01-14 2015-07-23 Mylan Laboratories Ltd. Purification of tenofovir alafenamide and its intermediates
CN105085571A (zh) * 2014-05-20 2015-11-25 四川海思科制药有限公司 替诺福韦艾拉酚胺复合物及其制备方法和用途
CZ2015384A3 (cs) * 2015-06-05 2016-12-14 Zentiva, K.S. Pevné formy Tenofovir alafenamidu
CA2987085A1 (en) 2015-06-17 2016-12-22 Gilead Sciences, Inc. Co-crystals, salts and solid forms of tenofovir alafenamide
WO2017118928A1 (en) 2016-01-06 2017-07-13 Lupin Limited Process for the separation of diastereomers of tenofovir alafenamide
CZ2016156A3 (cs) 2016-03-17 2017-09-27 Zentiva, K.S. Způsob přípravy diastereomerně čistého Tenofoviru Alafenamidu nebo jeho solí
WO2017203395A1 (en) * 2016-05-21 2017-11-30 Shilpa Medicare Limited Crystalline forms of tenofovir alafenamide hemi fumarate
TWI820984B (zh) 2017-01-31 2023-11-01 美商基利科學股份有限公司 替諾福韋埃拉酚胺(tenofovir alafenamide)之晶型
CN108484672A (zh) * 2018-05-23 2018-09-04 中国药科大学制药有限公司 磷丙替诺福韦的手性拆分方法
CN110283208B (zh) * 2018-06-22 2022-07-08 南京济群医药科技股份有限公司 一种替诺福韦艾拉酚胺的手性拆分方法
US11667656B2 (en) 2021-01-27 2023-06-06 Apotex Inc. Crystalline forms of Tenofovir alafenamide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020119443A1 (en) 2000-07-21 2002-08-29 Gilead Sciences, Inc. Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
TWI689513B (zh) 2011-10-07 2020-04-01 美商基利科學股份有限公司 抗病毒核苷酸類似物的製備方法
WO2014195724A1 (en) 2013-06-07 2014-12-11 Cipla Limited An efficient process for separation of diastereomers of 9-[(r)-2-[[(r,s)-[[(s)-1-(isopropoxycarbonyl)ethyl]amino]-phenoxyphosphinyl] methoxy]propyl]adenine

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9676803B2 (en) 2013-06-07 2017-06-13 Cipla Limited Efficient process for separation of diastereomers of 9-[(R)-2-[[(R,S)-[[(S)-1-(isopropoxycarbonyl)ethyl]amino]-phenoxyphosphinyl]methoxy]propyl]adenine

Also Published As

Publication number Publication date
WO2014195724A1 (en) 2014-12-11
US20160122373A1 (en) 2016-05-05
EP3004121A1 (en) 2016-04-13
ZA201404147B (en) 2016-01-27
US9676803B2 (en) 2017-06-13
CA2914381A1 (en) 2014-12-11

Similar Documents

Publication Publication Date Title
IN2013MU01967A (enEXAMPLES)
IN2014MU00118A (enEXAMPLES)
CR20140204A (es) Métodos para preparar análogos nucleotídicos antivirales
MD20140011A2 (en) Tenofovir alafenamide hemifumarate
UA111186C2 (uk) Способи та композиції для одержання норибогаїну з воакангіну
MX2016011641A (es) Procedimiento de preparacion de proteinas plasmaticas humanas.
MX2015002487A (es) Proceso para la preparacion de teneligliptina.
HK1256033A1 (zh) 用於刺激免疫系统的肽
GEP201706626B (en) Synthesis of (s)-nifuratel
GB2509659A (en) Process for preparing buprenorphine
NZ714378A (en) Polymorphic forms of nilotinib hydrochloride
IN2014MU00455A (enEXAMPLES)
TW201613953A (en) Process for the preparation of cyclic depsipeptides
NZ720106A (en) A process for the preparation of regadenoson
PH12014501327A1 (en) Processes for making magnolol analogs
PH12014501367A1 (en) Processes for making magnolol and derivatives thereof
IN2013MU01113A (enEXAMPLES)
MY183980A (en) Commercial scale process for production of prrsv
IN2014DN10209A (enEXAMPLES)
MX2017012027A (es) Desaminacion de nucleosidos organofosforados.
NZ711328A (en) A process for preparation of (2s, 5r)-7-oxo-6-sulphooxy-2-[((3r)-pyrrolidine-3-carbonyl)-hydrazino carbonyl]-1,6-diaza-bicyclo[3.2.1]octane
HUE048610T2 (hu) Eljárás bisz(szilil)amino csoportot tartalmazó szilánvegyület elõállítására
GB2564185A (en) Process for the preparation of derivatives of benzodioxole
TW201612142A (en) Process for preparing 3-chloro-2-vinylphenol
MX385963B (es) Procedimiento para la preparacion de 4-amino-1-( (1s, 4r, 5s) -2-fluoro-4,5-dihidroxi-3-hidroximetil-ciclopent-2-enil)-1h-pirimidin-2-ona.